Literature DB >> 15496392

Comparative analysis of Clostridium difficile clinical isolates belonging to different genetic lineages and time periods.

Patrizia Spigaglia1, Paola Mastrantonio1.   

Abstract

Recent studies have shown that Clostridium difficile strains with variant toxins and those with resistance to macrolide-lincosamide-streptogramin B (MLSB) are increasingly causing severe disease and outbreaks in hospital settings. Here, the pathogenicity locus (PaLoc), the acquisition of binary toxin, and the genotypic and phenotypic characteristics of antibiotic resistance of 74 C. difficile clinical strains isolated from symptomatic patients in Italy during different time periods were studied. These strains were found to belong to two different lineages, and those isolated before 1991 were genetically unrelated to the more recent strains. The majority of recent C. difficile strains showed variations in toxin genes and in the toxin negative regulator (tcdC) and had the binary toxin. In 62 % of them, variations in tcdC and the presence of the binary toxin were associated. Five classes of susceptibility/resistance pattern (EC-a to -e) for erythromycin and clindamycin were identified in all strains studied. Most of the recent isolates belonged to EC-d and EC-e and, although erythromycin-resistant in vitro, did not harbour the commonly associated ermB determinant. Interestingly, two strains of the EC-d class were resistant to clindamycin only after induction with subinhibitory concentrations of the antibiotic. A decrease in tetracycline and chloramphenicol MIC values was also observed in the recently isolated strains, associated with less frequent detection of the catD and tetM genes. Two tetM-positive strains were resistant in vitro only after induction with subinhibitory concentrations of the antibiotic. The acquisition of the binary toxin, the possible increase in toxin production due to a mutated negative regulator and a decrease in the fitness cost as a result of lower levels of antibiotic resistance or other mechanisms may have led to the successful establishment of these new phenotypes, with potentially serious clinical implications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15496392     DOI: 10.1099/jmm.0.45682-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  36 in total

Review 1.  Review: Clostridium difficile-associated disorders/diarrhea and Clostridium difficile colitis: the emergence of a more virulent era.

Authors:  Perry Hookman; Jamie S Barkin
Journal:  Dig Dis Sci       Date:  2007-02-16       Impact factor: 3.199

2.  Emergence of Clostridium difficile NAP1 in Latin America.

Authors:  Carlos Quesada-Gómez; César Rodríguez; María del Mar Gamboa-Coronado; Evelyn Rodríguez-Cavallini; Tim Du; Michael R Mulvey; Manuel Villalobos-Zúñiga; Ricardo Boza-Cordero
Journal:  J Clin Microbiol       Date:  2009-11-25       Impact factor: 5.948

3.  The mosaic nature of intergenic 16S-23S rRNA spacer regions suggests rRNA operon copy number variation in Clostridium difficile strains.

Authors:  Nourkhoda Sadeghifard; Volker Gürtler; Michael Beer; Robert J Seviour
Journal:  Appl Environ Microbiol       Date:  2006-09-15       Impact factor: 4.792

Review 4.  Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection.

Authors:  Patrizia Spigaglia
Journal:  Ther Adv Infect Dis       Date:  2016-02

5.  Isolation and characterization of Clostridium difficile from shellfish and marine environments.

Authors:  Vincenzo Pasquale; Vincenza Jessica Romano; Maja Rupnik; Stefano Dumontet; Ivan Cižnár; F Aliberti; F Mauri; V Saggiomo; Karel Krovacek
Journal:  Folia Microbiol (Praha)       Date:  2011-09-08       Impact factor: 2.099

6.  Fucoidin prevents Clostridium difficile toxin-A-induced ileal enteritis in mice.

Authors:  A R F Barreto; I C Cavalcante; M V Castro; A F T A Junqueira; M R Vale; R A Ribeiro; M H L P Souza; G A C Brito
Journal:  Dig Dis Sci       Date:  2007-09-01       Impact factor: 3.199

7.  Investigation of toxin gene diversity and antimicrobial resistance of Clostridium difficile strains.

Authors:  Shanshan Zhu; Huaping Zhang; Xinsheng Zhang; Chao Wang; Guangming Fan; Weifeng Zhang; Gang Sun; Huihong Chen; Liming Zhang; Zhaoyun Li
Journal:  Biomed Rep       Date:  2014-07-08

8.  Genetic relatedness of Clostridium difficile isolates from various origins determined by triple-locus sequence analysis based on toxin regulatory genes tcdC, tcdR, and cdtR.

Authors:  Philippe J M Bouvet; Michel R Popoff
Journal:  J Clin Microbiol       Date:  2008-10-01       Impact factor: 5.948

9.  Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A.

Authors:  Ruth Murray; Dave Boyd; Paul N Levett; Michael R Mulvey; Michelle J Alfa
Journal:  BMC Infect Dis       Date:  2009-06-28       Impact factor: 3.090

10.  Characterization of Clostridium difficile isolates using capillary gel electrophoresis-based PCR ribotyping.

Authors:  A Indra; S Huhulescu; M Schneeweis; P Hasenberger; S Kernbichler; A Fiedler; G Wewalka; F Allerberger; E J Kuijper
Journal:  J Med Microbiol       Date:  2008-11       Impact factor: 2.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.